2012 annual financial data
Lisata Therapeutics 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -96.67%.
Operating income was -30,386,000 USD and net income was -54,782,000 USD.
Operating cash flow was -13,852,518 USD.
Get free Lisata Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 14,330,000 USD
- Operating income
- -30,386,000 USD
- Net income
- -54,782,000 USD
- Operating cash flow
- -13,852,518 USD